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ABSTRACT 
 
Objective: This prospective comparative study determined the efficacy of type III tympanoplasty using homologous septal spur cartilage in patients 
with chronic otitis media (COM). 
Methods: We selected patients by random sampling. Complete otolaryngological examination including otological examination, tuning fork tests, pure 
tone audiometry (PTA), and relevant investigations was done. Post-tympanoplasty residual air-bone gap (ABG) was graded. Type III tympanoplasty 
was done for all and followed up until month 6. 
Results: Of 50 patients, 70.0% were men. Mean age was 27.72±10.81 years, 24 and 26 patients underwent type III-A and III-B tympanoplasty, 
respectively. Pre-operative mean PTA and ABG was 50.08 dB and 38.27 dB, respectively. Pre-operative ABG of 31–60 dB was seen in 41 patients while 
nine had an ABG of 0–30 dB. Overall, pre and post-operative PTA was 50.24 dB and 28.54 dB, respectively. Overall, pre- and post-operative ABG was 
38.32 dB and 16.40 dB (III-A 36.92 dB and 14.79 dB; III-B 39.62 dB and 17.88 dB). Mean overall hearing gain postoperatively in PTA was 21.70 dB 
(type III A 22.33 dB, III B −21.115 dB). Overall, ABG closure was 23.53 dB (type III-A 22.333 dB, III-B −21.115 dB). None had failure (>30 dB). Good 
ABG of 10–20 dB was seen in 72% and 78% of patients at month 3 and 6, respectively. 
Conclusion: Significant post-operative hearing improvement was seen in both types of tympanoplasty using homologous cartilage graft for ossicular 
reconstruction. Type III-A is better than type III-B as the stapes superstructure is vital for hearing. 
Keywords: Air-bone gap, chronic suppurative otitis media, Hearing improvement, Pure tone audiometry, Tympanoplasty type III. 
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Tympanoplasty is a procedure for the eradication of middle ear diseases 
and reconstruction of the hearing mechanism by repairing the tympanic 
membrane with or without ossiculoplasty. Following the eradication of 
the disease, the reconstruction of the tympanic membrane and ossicles 
is a prerequisite to restoring hearing. Different materials, natural or 
bioinert, are used in the reconstruction and restoration of the hearing 
mechanisms. The materials used are refashioned ossicles, cartilage, 
cortical bone, titanium prosthesis, hydroxyapatite, and synthetic 
plastipore. 
 
In surgical repair of hearing mechanism of the ear, several host factors 
come into play such as the size of perforation, Eustachian tube, function 
state of the middle ear mucosa, wound healing, the status of the 
ossicles, and degree of pneumatization of the mastoid [1]. Surgical 
consideration such as approaches (per meatal, end aural, and post 
aural), graft sources (temporalis fascia, a cartilage graft, and dura), 
placement of the graft, associated mastoid operation (intact canal wall 
and canal wall down), and ossiculoplasty also have a bearing on the 
success of the surgery. Hence, no single technique is best for all 
tympanoplasties. 
 
In cases where there is an extensive loss of ossicles, the homologous 
septal spur cartilage is used for the reconstruction of ossicles to bridge 
the gap between the remnant of stapes and the neo tympanic 
membrane. In the evaluation of the surgical success of tympanoplasty, 
an assessment of various host and surgical factors has been a subject of 
interest for many years and continues to be a challenge. 
 
The operational success of tympanoplasty can be evaluated in terms of 
the rate of graft uptake. However, to have a quantitative measurement 
of
 
subject’s hearing and to give scientific credibility to the results of the 
clinical tests, an audiometric evaluation of tympanoplasty can be done. 
Comparison of the pre and postoperative pure tone averages in speech 
frequencies and the air-bone gap (ABG) gives a complete picture of the 
improvement in hearing after surgery and also establishes a baseline 
for any changes (improvement/deterioration), which may occur as a 
result of treatment or due to the natural progression of disease. 
 
Type III tympanoplasty has shown satisfactory outcomes in chronic 
otitis media [COM], both in experimental [2] and clinical studies [3]. It 
also has shown a lesser ABG apart from hearing outcome [4]. Data on 
clinical outcome of type III tympanoplasty in Indian patients are 
limited. Hence, we evaluated the degree of hearing improvement after 
type III tympanoplasty using homologous cartilage. 
 
METHODS 
This study was conducted at a government Ear, Nose and Throat (ENT) 
hospital located in South India, after obtaining Institutional Ethics 
Committee's review and approval. Our objective was to determine the 
efficacy of type III homologous septal spur cartilage in the 
improvement of hearing in cases of chronic suppurative otitis media 
by comparing the pre- and post-operative pure tone audiogram. We 
included patients who underwent type III Tympanoplasty done using 
homologous spur cartilage, selected by random sampling. Patients 
with the sensorineural hearing loss, only or significantly better 
hearing ear, any intracranial complications of the ear disease, 
malignant neoplasm of the external or middle ear and those with 
persisting ear discharge postoperatively were excluded from the study. 
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Patients who satisfied the criteria for selection were taken as subjects 
of the study after taking a written informed consent; for those aged <18, 
consent from the parents and assent from the patients were obtained. 
The data of the patient were collected in a case proforma. After taking 
a detailed medical history, complete ENT evaluation including otological 
examination, tuning-fork tests were done to rule out any source of 
infection. Pure tone audiometry (PTA), relevant haematological and 
radiological investigations to assess for fitness for surgery, culture, and 
sensitivity of ear discharge, and microscopic examination were done. 
Pure tone audiometric evaluation was done for all patients in a 
soundproof room with GSI 68 diagnostic audiometer, with standard 
procedures by the same audiologist both preoperatively and 
postoperatively. Audiometric testing was performed at 500, 1000, 2000, 
and 4000 Hz. 
 
X-ray mastoids Schuller’s view was taken for all. Patients were managed 
with type III tympanoplasty (Figs. 1 and 2), with cortical mastoidectomy 
or canal wall down mastoidectomy as indicated. In the postoperative 
period, all were followed up on an outpatient basis, once weekly in the 
first month, once a month later on and at third and sixth month to 
determine the hearing improvement. Post-tympanoplasty residual ABG 
was graded as per Kartush (1994) Classification [5]. 
 
Statistical analysis 
We tested the null hypothesis that stated: “There is no significant difference 
in the mean values between the two groups, i.e., µ1=µ2.” Our alternate 
hypothesis stated, “There is a significant difference in the mean values 
between the two groups, i.e., µ1≠µ2.” We kept the level of Significance: 
α=0.05. Appropriate statistical tests were used (Student’s t-test). 
 
Decision criterion 
We compared the p-value with the level of significance. We rejected 
the null hypothesis and accepted the alternate hypothesis, if p was 
<0.05. We accepted the null hypothesis when p≥0.05. 
 
Results were interpreted in terms of frequency, mean, standard 
deviation, and range. Tables and figures were used to tabulate and 
depict the results. 
 
RESULTS 
We included 50 eligible patients meeting the selection criteria. There 
were 35 (70.0%) men and 15 (30.0%) women. Mean age of our study 
population was 27.72  years±10.81,  range  12–56  years  (Table  1). 
33 (66.0%) patients were aged <30 years (Table 2). 
 
Of 24 patients who underwent type III-A tympanoplasty, 14 (58.33%) 
were males and 10 (41.67%) were females; of 26 patients who 
underwent type III -B tympanoplasty, 21 (80.77%) were males and five 
(19.23%) were females. There was no significant association between 
type and gender (p>0.05). 
 
Ear discharge (n=50, 100%) and hearing impairment (n=45, 90%) 
were the common complaints. 
 
Right ear COM was seen in 24, left ear COM in 22 and 8 had bilateral 
involvement. Of the 50 cases, 26 were of mucosal type COM (52%) and 
24 squamosal type (48%). 
 
X-Ray mastoids (lateral oblique view) revealed sclerotic mastoid in 40 (80%) 
patients. Culture reports were sterile in 44 (88%); Moraxella catarrhalis in 
3 (06%) among those with mucosal type COM and Saprophytes (n=3) and 
Pseudomonas aeruginosa (n=1) were reported in squamosal type. 
 
Patients underwent Type III tympanoplasty with cortical mastoidectomy for 
mucosal type and canal wall down mastoidectomy for squamosal type, with 
ossiculoplasty using homologous cartilage graft. Of which 24 underwent 
Type III-A tympanoplasty and 26 underwent Type III-B tympanoplasty. 
 
The preoperative mean PTA and ABG were 50.08 dB, and 38.27 dB, 
respectively. Preoperative ABG of 31–60 dB was seen in 41 patients 
while nine had a gap of 0–30 dB. 
Post-operative audiometry was done at months 3 and 6 for all.  In our 
study, the overall pre and post-operative PTA was 50.24dB and 
28.54dB, respectively (Table 3). 
 
Overall, pre and post-operative ABG was 38.32 dB and 16.40 dB, 
respectively. The pre and post-operative ABG was 36.92 dB and 
 
Fig. 1: Homologous spur cartilage placed in type III-A 
tympanoplasty 
 
Fig. 2: Homologous spur cartilage placed in type III B 
tympanoplasty 
 
Table 1: Mean age of the study population 
Age (years) n Mean±SD Median Min Max 
Overall 50 27.72±10.81 24.5 12 56 
Type 3A 24 28.83±12.17 23.5 15 56 
Type 3B 26 26.69±9.50 26.0 12 45 
SD: Standard deviation; Sample size - 50.    
 
 
Table 2: Age distribution in the study 
Age in years    n (%) 
<20 15 (30.0) 
21–30 18 (36.0) 
31–40 8 (16.0) 
41–50 8 (16.0) 
>50 1 (02.0) 
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14.79 dB respectively, in type III-A tympanoplasty. In type III-B 
tympanoplasty, the pre and postoperative ABG was 39.62 dB and 
17.88 dB, respectively (Table 4). 
 
Overall, mean hearing gain postoperatively in PTA was 21.70 dB. In 
type III-A tympanoplasty, the hearing gain was 22.33 dB, and in type 
III-B tympanoplasty it was 21.115 dB. The overall ABG Closure was 
23.53 dB. It was 22.333 dB in type III-A tympanoplasty and 21.115 dB 
in Type III-B tympanoplasty. 
 
Post-tympanoplasty residual ABG was graded as per Kartush (1994) 
classification (Table 5). 
 
Complications 
At the end of 6 months all but two patients had ear dry; of the two 
patients who had ear discharge, one settled with oral and topical 
antibiotics. However, in the other patient, the ear discharge persisted 
due to infection. The tympanic graft was perforated. The patient was 
advised revision surgery at a later date. 
 
DISCUSSION 
The ultimate objective in treating COM is to clear infection by performing 
a proper cortical mastoidectomy in mucosal type and a modified radical 
mastoidectomy in Squamosal variety, thereby removing the pathology 
in total. The secondary aim was to improve hearing to the extent 
possible, with proper ossicular reconstruction. Tympanoplasty with 
canal wall up or down mastoidectomies has resulted in improvement 
in hearing loss in those with COM [6]. 
 
Although several new techniques and new implant materials have been 
developed since 1950, the search for the ideal implant is still on. We are 
yet to develop an entirely satisfactory method of reconstructing the 
ossicular chain. Homologous and autologous ossicles are in use for many 
years. However, the difficulty in procuring the ossicles and the fear of 
contracting diseases such as acquired immunodeficiency syndrome 
(AIDS) and hepatitis made surgeons look for other alternatives. Synthetic 
implants were devised for this purpose, but have a risk of inciting a foreign 
body reaction and become exposed through the tympanic membrane [7]. 
 
The analysis of success rates of various authors using autograft ossicles 
(69–70%) or homologous cartilage (78%) with that of other prostheses 
revealed similar success rate as with synthetic prostheses. 
 
The most commonly used autograft material has been the incus body, 
which is often reshaped to fit between the manubrium of the malleus 
and the stapes capitulum. The homologous cartilage (septal spur and 
tragal cartilage) is used as an alternative if both malleus and incus are 
destroyed. Homologous cartilage is usually taken from thick septal spur 
during septoplasty and is preserved in 90% isopropyl alcohol. It is used as 
an effective ossicular reconstructive material without the risk of foreign 
body reaction or extrusion that is associated with synthetic materials [7]. 
This procedure is considered to have the advantage of very low extrusion 
rate, technically easy to perform with less risk of residual disease [8]. 
 
Age at surgery is an important determining factor for the outcome. 
Studies have suggested that patients with COM have to be operated at 
an early age to achieve a satisfactory surgical outcome [9]. Mean age of 
our patients was 27.72 years with a range of 12–56 years; 66.0% of 
our patients were aged <30 years. Adhikari et al. [10] reported a range 
of 15–65 years and those who underwent type III tympanoplasty had a 
mean age of 29.35 years. Higher mean age was noted by Küçükkavruk 
et al. (39 years) [11]. We observed male preponderance (70.00%), 
similar to the observations of Adhikari et al. Similar to our study, 
Gupta et al. [12] too observed the at majority of their patients were 
aged <30 years, mean age of 24 years, the age range of 13–55 years. 
 
Table 3: Comparison of change in PTA (dB) and ABG (dB) from baseline within type 3A 
Parameter Time interval Mean SD SEM Mean difference  p-valuelue 
PTA (dB) Pre-operative 46.21 5.06 1.03 22.292 33.881 <0.001* 
 3 months operative 23.92 4.66 0.95    
 Pre-operative 46.21 5.06 1.03 22.333 28.914 <0.001* 
 6 months 23.88 4.76 0.97    
ABG (dB) Pre-operative 36.92 5.27 1.07 22.208 31.757 <0.001* 
 3 months operative 14.71 4.61 0.94    
 Pre-operative 36.92 5.27 1.07 22.125 28.588 <0.001* 
 6 months 14.79 4.39 0.90    
*Statistically significant difference. PTA: Pure tone audiometry, ABG: Air-bone gap, SD: Standard deviation, SEM: Standard error of the mean; Sample size - 50. 
 
Table 4: Comparison of change in PTA (dB) and ABG (dB) from baseline within type 3B 
Parameter Time interval Mean SD SEM Mean difference  p-valuelue 
PTA (dB) Pre-operative 53.96 8.33 1.63 20.462 16.188 <0.001* 
 3 months operative 33.50 8.36 1.64    
 Pre-operative 53.96 8.33 1.63 21.115 17.244 <0.001* 
 6 months 32.85 8.26 1.62    
ABG (dB) Pre-operative 39.62 6.86 1.35 21.077 24.897 <0.001* 
 3 months operative 18.54 5.58 1.09    
 Pre-operative 39.62 6.86 1.35 21.731 24.223 <0.001* 
 6 months 17.88 5.78 1.13    
*Statistically significant difference. PTA: Pure tone audiometry, ABG: Air-bone gap, SD: Standard deviation, SEM: Standard error of the mean; Sample size - 50. 
 
 Table 5: Post‑ operative residual ABG  
Post‑ operative residual ABG No. of cases at 3 montpostoperativeive (%) No. of cases at 6 montpostoperativeive (%) 
Excellent - <10 dB 6 (12) 3 (6) 
Good - 10–20 dB 36 (72) 39 (78) 
Fair - 21–30 dB 8 (16) 9 (18) 
Failure - >30 dB - - 
ABG: Air-bone gap; Sample size - 50.   
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Table 6: Heating results using different materiacategorisedzed in 10 dB 
Authors Materials used N Excellent (10 dB) (%) Good (11–20 dB) (%) Fair (21–30 dB) (%) 
Jackson et al. [16] PORP (Proplast) 55 12 (22) 15 (27) 17 (31) 
Berrenholz et al. [17] PORSilastictic) 33 7 (21.2) 9 (27.7) 5 (15.1) 
Batra et al. [1] Hydroxylapatite 20 2 (10) 9 (45) 6 (30) 
Dalchow et al. [19] Titanium 790 340 (43) 261 (33) 111 (14) 
Chole [7] Cartilage 102 26 (25.5) 40 (39.2) 24 (23.3) 
Harvey et al. [15] Cartilage 20 2 (10) 8 (40) 3 (15) 
RobertO'Reillylly [20] Incus 137 35 (25.5) 56 (40.9) 23 (16.8) 
Our results Cartilage 49 3 (6) 38 (76) 9 (18) 
The secondary goal of tympanoplasty is improving the hearing 
capacity, which, in turn, depends on the innate healing capacity, as 
well as on the perseverance of reconstruction. Wiatr et al. [13] 
analyzed the determinants of improvement in hearing after surgery in 
patients with COM. Presenre of granuoma related lesion in the middle 
ear, damage to ossicles, and closing ABG have been reported to be the 
significant determinants. Lee et al. [14] reported that PTA is essential in 
assessing the hearing capacity patient’s subjective hearing is 
determined by the pre- and post-operative air conduction threshold of 
>10 dB and ABG decrement of >20 dB [14] Mean pre and postoperative 
ABG of 25.36 dB and 7.36 dB was noted by Küçükkavruk et al. [11]. In 
our study, a mean residual ABG of 21.62 dB at 3 months and 22.38 dB 
was attained at 6 months, post-surgery, which was statistically 
significant. 
 
Hearing results in our study revealed a mean post-operative  ABG  of 
22.38 dB which is comparable to previous  studies  (16.9±9.8  dB to 
23.8 dB) [7,15]. Adhikari et al. [10] noted an improvement of 13.71%, 
from pre-operative air conduction threshold 51.05 dB  to  44.05  dB in 
6 month postoperative (p=0.0009). PTA ABG improvement was 14.4% 
with mean ABG 42.4 dB and 36.3 dB (p=0.0009), pre and 
postoperatively [10]. These results encourage us to opt for 
reconstruction of COM with easily available homologous cartilage. 
 
Various studies have compared different implant materials, and hearing 
was better with cartilage (Table 6). 
 
With the use of biological or synthetic implants, hearing results were 
good as Table 6. Post-operative residual ABG with titanium implants 
showed excellent results (43%) when patients were followed up for 
6–12 months. As compared to other prostheses postoperative hearing 
results are equally good. Although the septal spur cartilage as the 
prosthesis, has given more or less the same results, to assess the long-
term hearing results, a more extended follow-up period is required. We 
recommend a follow-up for 2 years for proper assessment of 
improvement in hearing as previous studies have noted satisfactory 
long-term improvement [21,22]. 
 
Shrestha et al. [23] concluded that type III tympanoplasty though 
showed  varied  hearing improvement results in significant 
improvement in PTA-ABG (range 15–61.2 dB). In their study, mean pre 
and postoperative ABG was 37.8 dB and 29.8 dB. 
 
Babu et al. [8] compared the hearing outcome among those who 
underwent type III A and B tympanoplasty. They reported the average 
pre-operative mean ABG of 43.64 dB (type III-A 39.7 dB and type III-B 
46.9 dB). The mean ABG at month 6 follow-up was 18.9 dB (type III-A 
15.2 dB and type III-B 22.11 dB). In our study, the pre-operative mean 
ABG was 38.27 dB±5.82 (type III-A 36.92 dB±5.27 and type III-B 
39.62dB, 6.86) and postoperative, the ABG was 16.34dB±5.13 III-A III 
A 14.79dB±4.39 and type III-B 17.88d B±5.78). Our results are 
comparable to that reported by Babu et al. 
 
We graded post-tympanoplasty residual ABG as per Kartush 
Classification. None of our patients had failure (>30 dB). Good ABG of 
10–20 dB was seen in 72% and 78% of patients at month 3 and month 
6. Excellent results were seen in 12% and 6% of patients at month 3 and 
month 6. Type III-A showed better results than type III- B as the stapes 
superstructure is vital for hearing. Long-term follow-up would have 
helped us to assess the changes if any. 
 
Two of our patients had ear discharge; one patient responded to 
treatment, while it persisted in other due to infection. The tympanic 
graft was performed. The patient was advised revision surgery at a 
later date. 
 
Similar to our study, most of the studies on type III tympanoplasty had 
small number of patients. We limited our follow-up period to 6 months, 
as many patients drop out after this period; we did not evaluate the 
factors that contribute and influence the outcome. Comparison with 
other types would have given insight which surgery would be best 
suited for our patients. 
 
CONCLUSION 
Significant post-operative hearing improvement was seen in both type 
III-A and Type III-B tympanoplasty using homologous cartilage graft 
for ossicular reconstruction at 6 months post-operative follow-up. Our 
results showed that Type III-A is better option than type III-B as the 
stapes superstructure is vital for hearing. 
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